139 related articles for article (PubMed ID: 15666998)
1. Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol.
Sapi E; Alvero AB; Chen W; O'Malley D; Hao XY; Dwipoyono B; Garg M; Kamsteeg M; Rutherford T; Mor G
Oncol Res; 2004; 14(11-12):567-78. PubMed ID: 15666998
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells.
Alvero AB; O'Malley D; Brown D; Kelly G; Garg M; Chen W; Rutherford T; Mor G
Cancer; 2006 Feb; 106(3):599-608. PubMed ID: 16388521
[TBL] [Abstract][Full Text] [Related]
3. Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells.
Kamsteeg M; Rutherford T; Sapi E; Hanczaruk B; Shahabi S; Flick M; Brown D; Mor G
Oncogene; 2003 May; 22(17):2611-20. PubMed ID: 12730675
[TBL] [Abstract][Full Text] [Related]
4. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
Kluger HM; McCarthy MM; Alvero AB; Sznol M; Ariyan S; Camp RL; Rimm DL; Mor G
J Transl Med; 2007 Jan; 5():6. PubMed ID: 17257402
[TBL] [Abstract][Full Text] [Related]
5. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
6. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.
Halder J; Landen CN; Lutgendorf SK; Li Y; Jennings NB; Fan D; Nelkin GM; Schmandt R; Schaller MD; Sood AK
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8829-36. PubMed ID: 16361572
[TBL] [Abstract][Full Text] [Related]
8. Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition.
Miyamoto M; Takano M; Aoyama T; Soyama H; Ishibashi H; Kato K; Iwahashi H; Takasaki K; Kuwahara M; Matuura H; Sakamoto T; Yoshikawa T; Furuya K
Anticancer Res; 2018 Jan; 38(1):301-306. PubMed ID: 29277787
[TBL] [Abstract][Full Text] [Related]
9. Involvement of BH3-only proapoptotic proteins in mitochondrial-dependent Phenoxodiol-induced apoptosis of human melanoma cells.
Yu F; Watts RN; Zhang XD; Borrow JM; Hersey P
Anticancer Drugs; 2006 Nov; 17(10):1151-61. PubMed ID: 17075314
[TBL] [Abstract][Full Text] [Related]
10. The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer.
Munkarah AR; Ali-Fehmi R; Jiang JZ; Elhammady E; Malone JM; Saed GM
Anticancer Drugs; 2007 Sep; 18(8):889-96. PubMed ID: 17667594
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
Sasaki H; Sheng Y; Kotsuji F; Tsang BK
Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D
Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139
[TBL] [Abstract][Full Text] [Related]
13. miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis.
Ge G; Zhang W; Niu L; Yan Y; Ren Y; Zou Y
Oncol Rep; 2016 Mar; 35(3):1816-22. PubMed ID: 26676658
[TBL] [Abstract][Full Text] [Related]
14. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
[TBL] [Abstract][Full Text] [Related]
15. Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel.
Kolfschoten GM; Hulscher TM; Duyndam MC; Pinedo HM; Boven E
Biochem Pharmacol; 2002 Feb; 63(4):733-43. PubMed ID: 11992642
[TBL] [Abstract][Full Text] [Related]
16. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells.
Herst PM; Petersen T; Jerram P; Baty J; Berridge MV
Biochem Pharmacol; 2007 Dec; 74(11):1587-95. PubMed ID: 17904534
[TBL] [Abstract][Full Text] [Related]
17. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
[TBL] [Abstract][Full Text] [Related]
18. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins.
Li J; Feng Q; Kim JM; Schneiderman D; Liston P; Li M; Vanderhyden B; Faught W; Fung MF; Senterman M; Korneluk RG; Tsang BK
Endocrinology; 2001 Jan; 142(1):370-80. PubMed ID: 11145600
[TBL] [Abstract][Full Text] [Related]
19. Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.
Chao H; Wang L; Hao J; Ni J; Chang L; Graham PH; Kearsley JH; Li Y
Cancer Lett; 2013 Feb; 329(1):17-26. PubMed ID: 22995071
[TBL] [Abstract][Full Text] [Related]
20. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
Saed GM; Fletcher NM; Diamond MP; Morris RT; Gomez-Lopez N; Memaj I
Gynecol Oncol; 2018 Mar; 148(3):567-575. PubMed ID: 29329880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]